Skip to search formSkip to main contentSkip to account menu

Talampanel

Known as: (R)-(-)-1-(4-Aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine, 1-(4'-aminophenyl)-3-acetyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine, 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)benzodiazepine 
A synthetic derivative of dioxolo-benzodiazepine with anti-seizure activity. Talampanel antagonizes the AMPA (alpha-amino-3-hydroxy-5-methyl-4… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Glioblastoma multiform disease and pathological conditions are known from two decades. The two genetic pathways de novo (primary… 
2009
2009
La presente invention concerne un procede de traitement d’un patient humain atteint de sclerose laterale amyotrophique (ALS… 
2008
2008
2014 Background: Recent findings suggest that Ca2+-permeable AMPA receptors play a crucial role in the proliferation and mobility… 
2008
2008
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following… 
2008
2008
Number Treatment NumberOfPatients PatientCatagory Outcome 13014 Accelerated RT/Temodar 28 New GBM mPFS=6m, PFS6=48%, OS1yr=48… 
Review
2007
Review
2007
Experimental models of epilepsy or status epilepticus (SE) provide evidence that seizures result in diffuse brain damage. Other… 
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials reported in current literature and congresses. The data…